I would have expected higher revenues by now with the combined revenue of Murray Meds and ECS. The combined losses of both entities will probably result in lower cash reserves in 4C statement. I imagine there is a revenue raising imminent. Given the previous financials, it is most likely to occur in next two weeks. I like the long term outlook for this company.
GLTAH
I would have expected higher revenues by now with the combined...
Add ECS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.48M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $86.21K | 4.480M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1100835 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 540000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.9¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.0¢ | 2.0¢ | 1.9¢ | 709712 | ||
| Last updated 14.48pm 06/05/2024 ? | |||||
| ECS (ASX) Chart |